Acid Suppression Medications Reduce Risk of Oesophageal Adenocarcinoma in Barrett's Oesophagus: A Nested Case-Control Study in US Male Veterans

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14895
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

GATA6 Expression in Barrett's Oesophagus and Oesophageal Adenocarcinoma

Digestive and Liver Disease
HepatologyGastroenterology
2015English

Epigenetic Biomarkers in Progression From Non-Dysplastic Barrett's Oesophagus to Oesophageal Adenocarcinoma: A Systematic Review Protocol

BMJ Open
Medicine
2016English

Repurposing of KLF5 Activates a Cell Cycle Signature During the Progression From Barrett's Oesophagus to Oesophageal Adenocarcinoma.

2020English

Research Priority Setting in Barrett's Oesophagus and Gastro-Oesophageal Reflux Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2017English

Helicobacter Pylori Infection and the Risks of Barrett's Oesophagus: A Population-Based Case-Control Study

International Journal of Cancer
Cancer ResearchOncology
2011English

Risk of Malignant Progression in Patients With Barrett's Oesophagus: A Dutch Nationwide Cohort Study

Gut
Gastroenterology
2010English

Barrett's Oesophagus.

Postgraduate Medical Journal
Medicine
1998English

Dietary Fat Intake in the Aetiology of Barrett's Oesophagus and Oesophageal Adenocarcinoma: Data From a Prospective Cohort Study (EPIC-Norfolk) Using 7-Day Food Diary Data

Gut
Gastroenterology
2011English

Neuromuscular Function of the Human Lower Oesophageal Sphincter in Reflux Disease and Barrett's Oesophagus

Gut
Gastroenterology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy